Skip to content

Acupuncture in Myasthenia Gravis (AcuMG)

Acupuncture Treatment for Individuals With Myasthenia Gravis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05230082
Enrollment
24
Registered
2022-02-08
Start date
2022-05-25
Completion date
2024-04-30
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia Gravis

Brief summary

The purpose of the study is to determine the effect acupuncture treatment on individuals with a diagnosis of Myasthenia Gravis (MG). A total of 20 people with MG will be enrolled in this study to receive acupuncture treatment 2 times a week for 12 weeks. Participants will be randomized into two groups: 1) Immediate start and 2) Delayed start (12 weeks). The delayed start group will act as a control group for the first 12 weeks, but then receive acupuncture treatment for 12 weeks. It is hypothesized that patients with MG who receive acupuncture treatment will have improved quality of life and activities of daily living compared to no treatment.

Interventions

OTHERAcupuncture

Acupuncture treatments will be separated by a minimum of two days and a maximum of 14 days. Treatment sessions will be identical for both groups. Standard, sterile stainless-steel, disposable needles will be inserted at acupuncture points with a total of 18 needles for each treatment session. The depth of the needle will be approximately 10-20 millimeters. Needles will be left in place for 30 minutes.

Sponsors

HealthPartners Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Ability to provide and provision of signed and dated informed consent form * Age 18-80 * Diagnosis of MG

Exclusion criteria

* Non-English speaking * Participation in acupuncture treatment outside of the study, while enrolled * History of any other serious neurological, psychiatric, chronic pain disorders, or seizures * History of bleeding diathesis, other bleeding disorders, or syncope with needle puncture * History of cardiac arrhythmia or current pacemaker, neurostimulator, or other implanted stimulation device * Recent or active substance use disorder * Women who are currently pregnant, lactating, or planning to become pregnant during the study * Any other medical conditions that could affect their ability to participate in acupuncture treatments for the study duration (as determined by study investigators) * Active participation or past participation ≤3 months in any other interventional study. * Unwilling to participate in all study related activities

Design outcomes

Primary

MeasureTime frameDescription
To Determine the Effect of Acupuncture on Quality of Life in Patients With MGpre-acupuncture treatment and post-acupuncture treatmentA brief 15-item disease specific questionnaire. Myasthenia gravis-quality of life 15 (MG-QOL15). A higher score indicates a lower quality of life.\[range: 0-30\]

Secondary

MeasureTime frameDescription
To Determine the Effect of Acupuncture on Activities of Daily Living in Patients With MGpre-acupuncture treatment and post-acupuncture treatmentA brief 8-item disease specific questionnaire. Myasthenia gravis-activities of daily living (MG-ADL). A higher score indicates activities of daily living are more difficult.\[range: 0-24\]

Countries

United States

Participant flow

Participants by arm

ArmCount
Immediate Start
Patients will receive acupuncture treatment two times per week for 12 weeks. Acupuncture: Acupuncture treatments will be separated by a minimum of two days and a maximum of 14 days. Treatment sessions will be identical for both groups. Standard, sterile stainless-steel, disposable needles will be inserted at acupuncture points with a total of 18 needles for each treatment session. The depth of the needle will be approximately 10-20 millimeters. Needles will be left in place for 30 minutes.
10
Delayed Start
Patients will act as control group for the first 12 weeks then will receive acupuncture treatment two times per week for 12 weeks. Acupuncture: Acupuncture treatments will be separated by a minimum of two days and a maximum of 14 days. Treatment sessions will be identical for both groups. Standard, sterile stainless-steel, disposable needles will be inserted at acupuncture points with a total of 18 needles for each treatment session. The depth of the needle will be approximately 10-20 millimeters. Needles will be left in place for 30 minutes.
14
Total24

Baseline characteristics

CharacteristicImmediate StartTotalDelayed Start
Age, Continuous66 years
STANDARD_DEVIATION 12
62 years
STANDARD_DEVIATION 13
59 years
STANDARD_DEVIATION 13
Diagnosis Classification
Base treatment
1 Participants1 Participants0 Participants
Diagnosis Classification
Stagnation pronounced
1 Participants4 Participants3 Participants
Diagnosis Classification
Withdrawn before classification
2 Participants4 Participants2 Participants
Diagnosis Classification
Yang deficiency
4 Participants9 Participants5 Participants
Diagnosis Classification
Yin deficiency
2 Participants6 Participants4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants24 Participants14 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants3 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
8 Participants21 Participants13 Participants
Sex: Female, Male
Female
4 Participants12 Participants8 Participants
Sex: Female, Male
Male
6 Participants12 Participants6 Participants
Time since MG Diagnosis6 years
STANDARD_DEVIATION 8
8 years
STANDARD_DEVIATION 9
10 years
STANDARD_DEVIATION 11

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 100 / 140 / 14
other
Total, other adverse events
5 / 101 / 108 / 140 / 14
serious
Total, serious adverse events
1 / 100 / 100 / 140 / 14

Outcome results

Primary

To Determine the Effect of Acupuncture on Quality of Life in Patients With MG

A brief 15-item disease specific questionnaire. Myasthenia gravis-quality of life 15 (MG-QOL15). A higher score indicates a lower quality of life.\[range: 0-30\]

Time frame: pre-acupuncture treatment and post-acupuncture treatment

Population: Participants withdrew prior to the post-treatment measurement.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate StartTo Determine the Effect of Acupuncture on Quality of Life in Patients With MGpre-treatment10.8 score on a scaleStandard Deviation 6.7
Immediate StartTo Determine the Effect of Acupuncture on Quality of Life in Patients With MGpost-treatment3.6 score on a scaleStandard Deviation 2
Delayed StartTo Determine the Effect of Acupuncture on Quality of Life in Patients With MGpre-treatment9.4 score on a scaleStandard Deviation 7.4
Delayed StartTo Determine the Effect of Acupuncture on Quality of Life in Patients With MGpost-treatment8.3 score on a scaleStandard Deviation 7
Secondary

To Determine the Effect of Acupuncture on Activities of Daily Living in Patients With MG

A brief 8-item disease specific questionnaire. Myasthenia gravis-activities of daily living (MG-ADL). A higher score indicates activities of daily living are more difficult.\[range: 0-24\]

Time frame: pre-acupuncture treatment and post-acupuncture treatment

Population: Participants withdrew prior to the post-treatment measurement.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate StartTo Determine the Effect of Acupuncture on Activities of Daily Living in Patients With MGPre-treatment5.0 score on a scaleStandard Deviation 3.1
Immediate StartTo Determine the Effect of Acupuncture on Activities of Daily Living in Patients With MGPost-treatment2.3 score on a scaleStandard Deviation 1.6
Delayed StartTo Determine the Effect of Acupuncture on Activities of Daily Living in Patients With MGPre-treatment3.6 score on a scaleStandard Deviation 3
Delayed StartTo Determine the Effect of Acupuncture on Activities of Daily Living in Patients With MGPost-treatment3.5 score on a scaleStandard Deviation 2.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026